Sign in
BF

BARFRESH FOOD GROUP INC. (BRFH)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 2025 revenue was $1.63M, up 11% year over year, with gross margin at 31.1%; net loss improved to $0.88M and Adjusted EBITDA loss narrowed to $0.60M. Management reiterated expectations for stronger H2 as supply constraints resolve and inventory builds ahead of the school season .
  • Significant miss vs Wall Street on revenue ($1.63M actual vs $2.14M consensus) and EBITDA (−$0.79M actual vs −$0.62M consensus); EPS was in line at −$0.06. The miss reflects trial/development costs and bottling/logistics disruptions that persisted through Q2 [*]
  • Guidance lowered: FY 2025 revenue cut to $12.5–$14.0M from $14.5–$16.6M, citing greater-than-anticipated production/logistics impact in H1; management expects H2 revenue and margins to rise vs H1 as newly installed equipment enables capacity ramp .
  • Near-term stock narrative catalyst: guidance reset plus clear capacity normalization path; management highlighted new higher-capacity bottling partner coming online in Jan 2026 (expected to exceed replaced manufacturer’s volume by ~400%), and only ~5% penetration in education, implying a long runway .

What Went Well and What Went Wrong

What Went Well

  • “We delivered 11% year-over-year revenue growth in the second quarter with solid margin performance… our co-manufacturing partner completed their equipment installation… which resolves the temporary inefficiencies and elevated logistics costs that impacted our first half results” .
  • Operating discipline: G&A fell to $673K from $865K YoY; Adjusted EBITDA loss improved to −$600K from −$682K YoY, demonstrating cost control despite supply challenges .
  • Strategic capacity progress: “We now have two manufacturers producing product… positioned for stronger performance in the second half of the year,” with additional high-capacity bottling manufacturer slated for January 2026 to replace an incumbent and exceed capacity by ~400% .

What Went Wrong

  • Revenue and EBITDA missed consensus as bottling/logistics constraints lasted through Q2; products were temporarily taken off some menus due to bottle shortages, dampening sales momentum until inventory build post-installation [*].
  • Gross margin contracted YoY to 31.1% from 34.8%, driven by product mix and trial/development inefficiencies at the new manufacturer during early production .
  • Guidance lowered for FY 2025 (now $12.5–$14.0M vs prior $14.5–$16.6M), reflecting greater first-half operational impact than anticipated; management highlighted continued transition efforts to stabilize supply .

Financial Results

Income Statement Summary

MetricQ4 2024Q1 2025Q2 2025
Revenue ($USD)$2,788,000 $2,930,000 $1,625,000
Gross Margin %26.0% 30.7% 31.1%
Adjusted Gross Margin %30.0% 30.7% 31.1%
Net Loss ($USD)$(852,000) $(761,000) $(880,000)
Adjusted EBITDA ($USD)$(561,000) $(506,000) $(600,000)

Notes: YoY Q2 revenue +11% and gross margin 31.1% per release commentary . QoQ, revenue declined from Q1 due to lingering bottling/logistics issues .

Operating Expenses Detail

MetricQ4 2024Q1 2025Q2 2025
Selling, Marketing & Distribution ($USD; % Rev)$872,000; 31% $824,000; 28% $634,000; 39%
G&A ($USD)$620,000 $747,000 $673,000

Drivers: SMD percent up in Q2 given distribution/storage mix; G&A down YoY on lower personnel, legal/professional, and stock comp due to lower expected PSU attainment .

EPS (Diluted EPS - Continuing Operations)

MetricQ2 2024Q1 2025Q2 2025
Diluted EPS ($USD)$(0.07)*$(0.05)*$(0.06)*

Values retrieved from S&P Global.* [*]

Balance Sheet KPIs

MetricQ4 2024Q1 2025Q2 2025
Cash + Accounts Receivable ($USD)~$1.1M ~$3.4M ~$1.3M
Inventory ($USD)~$1.5M ~$1.1M ~$1.8M

Estimates vs Actual (Q2 2025)

MetricActualConsensusSurprise
Revenue ($USD)$1,625,000 $2,143,000*—$518,000 miss; —24% vs consensus*
EPS ($USD)$(0.06)*$(0.06)*In line*
EBITDA ($USD)$(793,000) $(616,000)*—$177,000 miss*

Values retrieved from S&P Global.* [*]

Non-GAAP Adjustments (Q2 2025)

  • Adjusted Gross Profit excludes manufacturing relocation costs; Adjusted EBITDA excludes stock comp, product-withdrawal legal dispute costs, manufacturing relocation, and business development expenses .
  • Management uses these measures for period-to-period core performance comparisons and internal planning .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Revenue ($USD)FY 2025$14.5–$16.6M $12.5–$14.0M Lowered
Gross Margin (directional)H2 2025 vs H1 2025Expect dramatic improvements in back half Expects increase in revenue and gross margin in H2 vs H1 Maintained (direction)

Context: Guidance cut reflects greater-than-anticipated bottling/logistics impact in H1; equipment installations completed at the second co-manufacturer support H2 ramp .

Earnings Call Themes & Trends

TopicPrevious Mentions (Q4 2024)Previous Mentions (Q1 2025)Current Period (Q2 2025)Trend
Manufacturing capacity & co-manufacturersExpanded capacity in Q4; onboarding created temp inefficiencies; installations targeted by end of Q2 2025 On track for full production by end of Q2 2025 Equipment installations completed at second co-manufacturer; inventory building; two manufacturers producing Improving/resolving
Bottling/logistics constraintsTemp dual-location process increasing supply chain costs Expected resolution by end of Q2 Persisted through Q2 with greater impact; now resolved per management Normalizing
Education channel penetration & bidsSales reach >95% of country; customer wins accelerating Positioned for 2025–2026 school year ~5% penetration; bidding concluding; menu re-adds expected post-supply normalization Expanding
Pop & Go 100% Juice Freeze PopsInitial revenue launched in Q4 —Large districts approving; positive start; focus on populous states Scaling early
Legal dispute (product withdrawal)Case progressing; expenses reflected Non-recurring legal costs noted No new developments; non-GAAP excludes associated costs Stable backdrop
Financing & liquidityReceivables and litigation financing; inventory build $3.0M equity raise in Feb 2025 Liquidity managed via equity comp, litigation, receivables financing Adequate flexibility
2026 bottling transition——New higher-capacity bottling manufacturer to start Jan 2026; expected ~400% of replaced manufacturer’s volume Capacity step-up ahead

Management Commentary

  • CEO perspective: “We delivered 11% year-over-year revenue growth… our co-manufacturing partner completed their equipment installation… As we enter our high selling season in the education channel, we now have two manufacturers producing product… our expanded production capabilities… create the foundation for improvements in both top and bottom-line performance… in the second half of the year.”
  • Longer-term capacity: “In January 2026, we are adding a higher capacity bottling manufacturer… This additional capacity is expected to exceed the volume of the manufacturer we are replacing by approximately 400%.”
  • CFO detail: Expanded bottle capacity drove revenue; GM down on mix and early-stage inefficiencies; G&A decreased YoY; building inventory ahead of school season; liquidity managed via equity comp, litigation financing, and receivables financing .

Q&A Highlights

  • Education bids and product placement: Large districts approved Pop & Go; bids still being finalized; customers that temporarily removed products due to bottle shortages expected to re-add upon consistent supply .
  • Inventory composition: ~$1.8M inventory at Q2 end was “mostly bottle” built over summer to prepare for the school year .
  • Product mix and capacity: Sales are about even between bottles and cartons; ~80% Twist & Go; current bottling at capacity; 2026 bottling capacity expected in the 20–25M range (bottles) with cartons having at least 3x current capacity available .
  • Regional strategy: Priority on more populated states for Pop & Go rollout; broader penetration expected with more bottling capacity .

Estimates Context

  • Q2 2025 vs consensus: Revenue $1.63M actual vs $2.14M consensus (miss), EPS −$0.06 actual vs −$0.06 consensus (inline), EBITDA −$0.79M actual vs −$0.62M consensus (miss). Management lowered FY revenue guidance; Street models may need to reduce H2 run-rate assumptions to align with the $12.5–$14.0M range and margin normalization pace [*].
  • Forward snapshots: Q3 2025 consensus revenue ~$4.15M (actual reported post period ~$4.23M), EPS −$0.01 est, EBITDA ~$0.12M est—implying expectation of capacity normalization into H2; however, guidance suggests a more conservative full-year envelope [*].

Values retrieved from S&P Global.* [*]

Key Takeaways for Investors

  • Q2 showed operational transition effects; the bottling/logistics issues persisted longer than expected, driving a revenue/EBITDA miss and a guidance reset, but equipment installations are complete and inventory is building for H2 .
  • Margin trajectory should improve as early-stage inefficiencies subside and supply chain normalizes; management explicitly expects higher revenue and gross margin in H2 vs H1 .
  • The FY 2025 guidance cut to $12.5–$14.0M resets expectations; watch for H2 execution to validate the normalization thesis and to frame FY 2026 with the higher-capacity bottling partner coming online in January .
  • Education channel penetration remains low (~5%), offering a substantial growth runway as bids conclude and menu placements resume; near-term catalysts include district approvals and Pop & Go scaling .
  • Expense discipline is evident (G&A down YoY; Adjusted EBITDA improved YoY), providing leverage as revenue capacity expands .
  • For trading: near-term volatility likely tied to H2 order flow and margin prints versus the “increase in H2” narrative; any slip in supply consistency or school bid outcomes could pressure sentiment, while clear capacity ramps and margin beats would be stock-positive .
  • Monitor legal dispute costs in non-GAAP adjustments and working capital (inventory build) as the company transitions through peak school season and ramps manufacturing .